CORPORATE & INVESTOR Corporate and Investor...
38
CORPORATE & INVESTOR PRESENTATION
Transcript of CORPORATE & INVESTOR Corporate and Investor...
Corporate and Investor Presentation
CORPORATE & INVESTOR PRESENTATION
ELEVATOR PITCH
Gufic Biosciences, with its Research & Development (R&D) prowess, is accredited with several pioneering initiatives and development of block buster pharma products
It manufactures over 50 products across wide therapeutic segments at its three plants in India with operations spread across India and 23+ mature and emerging pharma markets. It has a strong team of 1000+ people, including field executives and scientists
It has heavily invested in advanced automation technologies and IT infrastructure
It has amalgamated operations with EU GMP and Ukraine PICS approved group company, Gufic Lifesciences Pvt Ltd. Having an annual manufacturing capacity of 14.4 million vials, a large portfolio of lyophilized products, export presence and marketing authorizations for injections, it will further strengthen the Company’s competitiveness
With all this Gufic Biosciences is all set to ensure sustainable value creation for all its stakeholders
CORPORATE OVERVIEW
GUFIC BIOSCIENCES: ABOUT THE COMPANY
Gufic Biosciences Ltd is a fast-growing pharmaceutical player recognized for
its innovative, high-quality pharmaceutical and herbal products and a wide
range of APIs (Active Pharmaceutical Ingredients)
Established in 1984, it is a part of the Gufic Group that came into existence in 1970 under the helm of Late Shri Pannalal Choksi with headquarters in Mumbai
Engages in the manufacture, job work, marketing, distribution and sales of pharmaceutical products
Amongst the largest manufacturers of Lyophilized injections in India with fully automated lyophilization plant
Products widely circulated across 1,500+ hospital chains and leading medical facilities through an extensive network of 1000+ marketing representatives across India
ABOUT THE GUFIC GROUP
Gufic Group operates with the vision of achieving leadership in the
specialized medical segment, while making products affordable using
innovation and technology
PIONEERING
INITIATIVES
Lyophilization
Amoxicillin
Dispersible Kid Tab
Specialized Herbals
SPECIALITIES
Lyophilized
Products
Herbal
Formulations
Critical care
Medicines
Infertility Products
BLOCK BUSTER BRANDS
Sallaki
Guficol
Guficap
Canidula
Puretrig
Stretch Nil
Reputation:
GUFIC Group
Gufic Biosciences Ltd.
Gufic Lifesciences Pvt. Ltd.
Corporate Structure:
Gufic Lifesciences Pvt. Ltd. (GLPL) is a WHO GMP, EU GMP and Ukraine GMP
approved company with a total capacity of 1.2 million lyophilized vials a month
Its lyophilized product portfolio includes Antibiotic, Antifungal, Cardiac,
Infertility, Antiviral and proton-pump inhibitor segments
Already exporting Vancomycin, Clarithromycin injection to Germany
and Azithromycin injection to Portugal
ABOUT GUFIC LIFESCIENCES
DRIVEN BY THE VISION TO MAKE SPECIALIZED HEALTHCARE AFFORDABLE
MISSIONLeadership in Healthcare Through
Innovation and Quality
VISION To achieve leadership in the specialized
medicinal segments and make products
available at a cost-effective rate using
innovation and technology to enhance
the welfare of the population
worldwide.
PRE 2000
JOURNEY OVER THE YEARS
1970s 1st Indian Company to
import a Lyophilizer (from Stokes, USA) to produce Lyophilized injections
1st Indian Company to manufacture children’s medicine, Kid Tab, in a dispersible tablet form
1974 1st Indian company to
launch Doxycycline injection and liquid oxytetracycline injection (breaking Pfizer’s monopoly)
1975 Introduced in India
Lyophilized B-Lactum Injections (Amoxicillin)
Zole ointment (Micanazole nitrate)
1980 Introduced new
freeze-dried to increase the bulk manufacturing of anti-biotic, anti-fungal and cardiac products
1984 1st company to
commercially produce Boswellia Serrata extract (100%) and tablets, which appeared in USP and B.P. (2012)
1986 Exported Boswellia Serrata
tablets to Germany
Introduced Zinc sulphatewith sulphadiazine cream with unique absorption base for fast-healing
1997 First time to manufacture and
market silver sulphadiazine eye drop with micron size particles
Sold popular brands Mox (Amoxicillin) and Zole (antifungals) to Ranbaxy
POST 2000
JOURNEY OVER THE YEARS
2000-2006 Focused on consumer
products like Roll-on, Stretch Nil, Onergy and Sanitary napkins
Ventured into Hybrid Seeds and Tissue culture
Developed 34 Lyophilized products
2007-2009 Commenced international exports
through Gufic Stridden
Initiated contract manufacturing of Lyophilized products
Received WHO-GMP certificate
2011-2016 Received patents for Anidulafungin
and Tigecycline Lyophilized products
Constructed a fully automated state-of-art plant at Navsari, Gujarat, India under the name Gufic Lifesciences Pvt. Ltd. and received EU-GMP approval
Approx. 300 work force
2017 Received patents for Rifabutin and Micafungin Lyophilized
products
Exported Vancomycin lyophilized injectable to Germany (European Union)
Manufacturing ramped to 2.4 million vials per month (MVPM) with scope to enhance to 3.6 MVPM
Approx. 1000 work force
2018 Amalgamated with Gufic Stridden Bio-Pharma Pvt Ltd,
which shall boost export opportunities in countries where it operated
Invested Rs. 52.89 million in R&D focused on development of external preparation and major parenteral products using new molecules
Approx. 1300 work force
BUSINESS SEGMENTS
CRITICARE & CRITICARE LIFE
Initiated in 2015
~40% contribution to Company’s revenues
900+ hospitals penetration
Fastest growing Criticare division in India
3rd largest supplier of injectable antibiotics to hospitals
Expertise in manufacturing affordable top-end Lyophilized injectable antibiotics
Key product offerings:
BUSINESS SEGMENTS
GUFIC FERTICARE
Initiated in 2016
Provides comprehensive fertility care through innovative, high-quality products
Manufacturing hormonal injectable since 8 years and has a dedicated hormone manufacturing block
Caters to manufacturing of hormonal products for 60% of Indian companies
PFS version of injectable hormones commercialized
First Indian company to launch Gufigest SR capsules
Key product offerings:
BUSINESS SEGMENTS
GUFIC SPARK
High thrust division
200+ dedicated field representatives
Caters ~25,000 General/Clinical practitioners, Pediatrician and Gynecologists
Launched 1st time in India:
o Cough syrup with oral dosing syringe
o Sertaconazole in ointment
o Lactic Acid Gel with unique applicator
Pipeline:
o Pain Management Liposomal
o Liposomal Iron
Key product offerings:
GUFIC HEALTHCARE
Leading manufacturer of specialized herbal medicines in India
Manufacturing unit in Belgaum, Karnataka, India
SALLAKI (Boswellia Serrata) – the flagship brand of the division has been the frontrunner for 35+ years in India and many European countries. There are more than 40 papers published in peer reviewed medical journals, 6 articles published in JIRA issue, two TV broadcasts on German network and six symposiums on Boswellia serrata in the ‘GA’ annual conferences
BUSINESS SEGMENTS
Key product offerings:
BUSINESS SEGMENTS
GUFIC BULK DRUGS
Bulk Drugs
GUFIC offers a varied therapeutic basket in its Bulk drugs/API division.
The categories of API’s manufactured are antifungals, antibacterial, anesthetics and intermediates for antifungals
Key product offerings:
MANUFACTURING FACILITIES AND CAPACITIES
CAPACITY:
Lyophilizer – 14.4 million(mn) vials per annum(p.a.)
Ampoule – 12 mn p.a.
Ointment – 6 mn tubes p.a.
Lotion – 6 mn bottles p.a.
Syrup – 6 mn bottles p.a.
KEY FEATURES:
Facility to manufacture specialized lyophilized, liquid injectables
Presence of EU-GMP and Ukraine PICS approved facility within the same premises with an additional capacity of 14.4 mn vials p.a., which caters to regulated markets like Europe, South Africa, CIS markets etc.
CERTIFICATIONS:
WHO GMP
Philippines BFAD
Nigeria NAFDAC
Cambodia MOH
Kenya PPB
Ethiopia FMHACA
Thailand MOH
Srilanka NMRA
NAVSARI PLANT
MANUFACTURING FACILITIES AND CAPACITIES
BARODA PLANT
CAPACITY:
Sanitary napkins – 0.7 mn per day
KEY FEATURES:
Equipped with automatic machine from Italy and China
BELGAUM PLANT
CAPACITY:
60 mn capsules p.a.
3.6 mn powder p.a.
KEY FEATURES:
Product manufactured is registered and exported to Germany and Switzerland
PRESENCE IN STRATEGIC LOCATIONS ACROSS THE GLOBE
NotePan-India excludes:Gufic Spark – Delhi, Orissa, Jammu & Kashmir (J&K), Himachal Pradesh (HP) and North-East (NE) * Gufic Healthcare – J&K and NE *Gufic Ferticare –J&K, HP and NE (present in Guwahati) *Criticare & Criticare Life – J&K and NE (present in Assam) Map not to scale
Our operations is spread across pan- India* and 23+ other countries worldwide
WELL-ENTRENCHED
PRESENCE IN INDIA
Pan-India distribution
network with 1400
distributors and 1180
field executives and
managers
38+ pharmaceuticals
companies
93000+ specialized
doctors
1500+ hospital chains
and medical facilities
GROWING PRESENCE
GLOBALLY
Product exports
across 23+ countries
Relationship with 46+
distributors
22 medical specialists
DIVERSE PORTFOLIO
60+ products
Products catering to
wide fast-growing
therapeutic areas
PROFESSIONAL
MANAGEMENT
30+ years average
experience of senior
management
Extensive knowledge
of promoters in
therapeutic gaps and
fast-growing
segments
OUR STRENGTHS
MANUFACTURING EXCELLENCE
Full scale commercial manufacturing with investments in automated machines
Adheres to WHO GMP and EU GMP/PICS guidelines
FINANCIALS
GUFIC BIOSCIENCES LTD – COMPARATIVE ANALYSIS
FINANCIAL HIGHLIGHTS
42.64 41.5773.24
90.21
160.21
0
50
100
150
200
FY14 FY15 FY16 FY17 FY18
Profit After Tax (Rs. in millions)
1230.11 1515.512021.98
2604.173041.19
0
1000
2000
3000
4000
FY14 FY15 FY16 FY17 FY18
Revenue from operations (Rs. in millions)
KEY BUSINESS ENABLERS
KEY ENABLERS
KEY ENABLERS
R&D API synthesis, first generic
launch, research collaboration and licensing of New drug delivery systems
Strategic collaboration with independent teams for introducing new products and strategies
Focus on developing better technologies to enhance efficacy, bio-availability and potency of existing and new products
Filed multiple process patents for many life-saving drugs injections
Marketing Core competency of super
specialty business Global presence Pan-India penetration in
leading corporate and tertiary care hospitals
110+ marketing authorizations worldwide and 130+ awaited
Supply Chain Integrated distribution
network across the entire value chain
Pan-India presence in 23 C&F’s
ERP system for real time visibility and co-ordination among all supply chain partners
Technology Upgraded hardware
infrastructure to virtualized platform Nutanix, a leader in HCI Gartner quadrant
Implementing Virtual Desktop Infrastructure (VDI) from Citrix for enhanced data security
Implemented pioneering Pharmacloud ERP system
Plan to move email solution to O365 for mobility and business continuity
STRATEGIC GROWTH PLAN
STRENGTHEN OFFERING
WAY FORWARD
Leverage collaboration with US, EU
and China based companies to
strengthen pipeline and enter the
field of cosmetics, immune-
oncology, diabetes and
neuropsychiatry
Botulin Toxin, Recombinant
products in Infertility and Immuno-
oncology, Nano liposomal platforms
& Monoclonal Antibodies
inlicensing
With government strongly focused
on bringing down healthcare costs,
Gufic is focused on achieving cost
efficiency by integrating backward
for developing core molecules via in
house or leased API plants. This will
also ensure self reliance
EXPLORE API DEVELOPMENT
PROMOTER, BOARD OF DIRECTOR AND MANAGEMENT PROFILES
FOUNDER
Late Shri Pannalal S. Choksi, Founder
He was a B-Pharm from L. M. College of Pharmacy, Ahmedabad.
He started the Company in 1970 and is accredited as being the first to launch blockbuster drugs in Antibiotics and Antifungals like Mox (Amoxycillin), Doxycycline inj, Zole (Micanazole Nitrate) etc. in India.
He was also the first to manufacture lyophilized injectables in India
SENIOR MANAGEMENT
Mr. Jayesh P. Choksi,Chairman and Managing Director
He is a Bachelor in Pharmacy with 40+ years of experience in the pharma sector. Under his stewardship, the Company has seen great success and diversified to Critical Care, Infertility, API manufacturing, Healthcare and Pharma verticals.
Philanthropy:
1. President – Utpal Shanghvi Global School
2. Member of Managing Committee - Shri. Vile Parle Kelavani Mandal
3. Mentor – Dr. Bhanuben Nanavati College of Pharmacy
Mr. Pranav J. Choksi,CEO & Whole Time Director
He is a Bachelor in Pharmacy from the Institute of ChemicalTechnology, University of Mumbai and have done Masters inBiotechnology from The John Hopkins University, USA and. He hasspecialization in Autologous Cancer Vaccines in the US.
He joined the Company in 2007 and has been instrumental indriving vital changes to take Gufic on the international arena. Thisled to the Company being awarded EU GMP for its formulationbusiness and US FDA for its API.
SENIOR MANAGEMENT
Dr. Debesh Das,President, Domestic Formulations
A dynamic and result oriented people leader with more than 20years of experience in pharmaceutical sales and marketing with aspecialization in chronic, acute and super specialty segment. He hasbeen a university topper throughout Bachelor in Pharmacy, MBAand PhD. Dr. Debesh Das Mr. Pranav J. Choksi
Mr. D.B.RoonghtaChief Financial Officer
He is a qualified Chartered Accountant with nearly 30 years of rich experience incorporate finance. He is experienced in leading the design of optimum capital structureand financial strategy . He is an enterprising leader who has effectively contributed toenhancing organizational processes.
KEY MANAGERIAL PERSONNEL
Mr. Nagesh YarrabathinaChief Operating Officer
He has nearly 18 years of experience with strong domain knowledge in qualityassurance, regulatory, international/national audits, strategy implementation insetting up a Pharmaceutical Industry with International standards.
KEY MANAGEMENT PERSONNEL
Mr. Mafatlal T. DaveTechnical Head
He is a B. Sc. (Chemistry, Physics) from Mumbai University and an A.I.C. (Associate of Institution of Chemist) from Chemist Institute, Calcutta. Initiating his career as an Assistant – Chemist at Therapeutic Chemical Research corporation, he has eventually gained over 53 years of experience in quality control and assurance, production, R&D and administration relating to pharmaceutical industry.
He is a member of editorial advisory Board at Journal of GMP and Industrial Pharmacy since 2009. He has been associated with the Gufic Group since 1969.
BOARD OF DIRECTORS
Dr. Balram Singh, Non-Executive Director
He is a B. Sc. (Chemistry, Biology), M. Sc. (Life Sciences, Major-Biochemistry) and M. Phil (Life sciences, Major-Biophysical chemistry) from India. He is doctorate in Chemistry with major in Biophysical Chemistry from Texas Tech University, USA. Starting his career as a Teaching & Research Assistant in the Department of Chemistry and Biochemistry, Texas in 1983, he has over 36 years of experience in the field of Science and Advancements.
He is the President & CEO of Prime Bio Inc and Neuromedicine Inc. and the Founding Director of Botulinum Research Center, MA (BRC). He has published over 13 books and 300 articles, the latest being on Protein Toxins in Modeling Biotechnology (Springer). He has been conducting research on botulinum and tetanus neurotoxins, vaccines, antidotes, drug delivery and Yoga, mind and consciousness along with Ayurvedic biotechnology.
Balram Singh with 36+ years of experience in field of Science and Advancements leads the R&D initiative at Gufic
BOARD OF DIRECTORSMrs. Hemal Milan Desai
Whole Time Executive Director
She is Cost Accountant from ICMA and has over 29 years of experience in the pharmaceutical industry,24 years of which have been with Gufic. She heads Direct and Indirect Taxation and is also responsiblefor overseeing Cost & NPPA related areas of the Company. She has been instrumental in strategicfinancial decision making and has headed the implementation of the same including mergers.
Mr. Pankaj Jayakumar Gandhi
Whole Time Director
He has been associated with Gufic for over two decades and has expertise in liasioning withRegulatory Authorities.
Dr. Sharat Shantilal GandhiIndependent Director
He is an MBBS from Grant Medical College, Bombay. He joined the Pharmaceutical industry in 1967 as Medical Adviser and over a span of 50 years worked on New Drug development, Regulatory Liaison, New drug registration of herbal drugs in Europe, marketing, training of field staff,clinical trials etc.
Mr. Shreyas Kantilal PatelIndependent DirectorHe has rich experience of over 35 years in the engineering industry. He is an entrepreneur with a manufacturingfacility for fabrication of press parts in Nasik.
Mr. Jagdish Dwarkadas ShahIndependent DirectorHe is a Chartered Accountant by profession. He started practice in 1980 and works as the Proprietor in his firmJ. Dwarkadas & Co.
Mr. Shrirang VaidyaIndependent DirectorHe has over 37 years of experience in banking industry with expertise in credit and audit compliance. Hestarted as a banker in a nationalized bank and thereafter joined as a DRO in a large Co-Operative bank,eventually becoming its Assistant General Manager. His association with the bank and his experience shall beworthwhile prove to Gufic in long run.
Mr. Gopal DaptariIndependent DirectorHe is an Advocate by Profession. He has around forty years of experience in labor & Industrial Laws related matters.
BOARD OF DIRECTORS
HUMAN RESOURCES & CORPORATE CITIZENSHIP
At Gufic, we believe in the age-old Chinese proverb –
“If you want one year of prosperity, grow grain. If you want ten years of
prosperity, grow trees. If you want one hundred years of prosperity, grow people”
NURTURING TALENT
How we grow people
Follow a culture of continuous learning to build competencies and encourage
personal development
Appreciate high-performers and work with weaker ones to enhance their skills
and productivity
Provide freedom to think out of box and bring new ideas
GUFIC HAS A TOTAL OF 1,000+ EMPLOYEES ACROSS INDIA AND 20+ IN OVERSEAS MARKET. THE COMPANY HAS TEAMS IN MOSCOW (RUSSIA), GERMANY (EUROPE) AND SHANGHAI (CHINA)
COMMUNITY HEALTHCARE, SANITATION AND HYGIENE
Assist people living in areas having inadequate medical facilities to get medical assistance
Provide free sanitary napkins for under privileged women
Provide world class medicines at cost price for 2500 patients annually
EDUCATION,
KNOWLEDGE AND
RESEARCH
Assist underprivileged
children to avail
education
Promote sports
Work with academic
institutions and provide
access to sophisticated
analytical equipment not
available with them at
zero cost
SOCIAL CARE
AND CONCERN
Generate employment
opportunities
Welfare of victims
of natural calamities
Save the Girl Child
campaign
CORPORATE CITIZENSHIP
Gufic’s strong focus on promoting
and supporting the cause of child
education has been recognized by
Smile Foundation
The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that all information relating to the context has been taken care off in the presentation and neither we undertake any obligation as to the regular updating of the information as a result of new information, future events or otherwise. We will accept no liability whatsoever for any loss arising directly or indirectly from the use of, reliance of any information contained in this presentation or for any omission of the information. The information shall not be distributed or used by any person or entity in any jurisdiction or countries were such distribution or use would be contrary to the applicable laws or Regulations. It is advised that prior to acting upon this presentation independent consultation / advise may be obtained and necessary due diligence, investigation etc. may be done at your end. You may also contact us directly for any questions or clarifications at our end.
This presentation contain certain statements of future expectations and other forward-looking statements, including those relating to our general business plans and strategy, our future financial condition and growth prospects, and future developments in our industry and our competitive and regulatory environment. In addition to statements which are forward looking by reason of context, the words ‘may, will, should, expects, plans, intends, anticipates, believes, estimates, predicts, potential or continue’ and similar expressions identify forward looking statements.
Actual results, performances or events may differ materially from these forward-looking statements including the plans, objectives, expectations, estimates and intentions expressed in forward looking statements due to a number of factors, including without limitation future changes or developments in our business, our competitive environment, technology and application, and political, economic, legal and social conditions in India. It is cautioned that the foregoing list is not exhaustive.
This presentation is not being used in connection with any invitation of an offer or an offer of securities and should not be used as a basis for any investment decision.
SAFE HARBOUR STATEMENT
Thank you
Gufic Biosciences Limited Regd. Office: 37, 1st Floor, Kamala Bhavan II, Swami Nityanand Road, Andheri (East), Mumbai - 400 069. (INDIA)Corp. Office: 1st to 4th Floor, S.M. House, 11 Sahakar Road, Vile Parle (East), Mumbai – 400 057. (INDIA)Tel.: +91 22 67261000Website: www.gufic.comEmail ID: [email protected]
Investor contact detailsName: Ms. Ami ShahEmail ID: [email protected].: +91-22-67261000
